Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Summary
The Department of the Army, through its Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND), is issuing a continuous Basic Agreement to build a network of partners that will develop, test, and field next‑generation CBRN medical countermeasures, including drugs, biologics, devices, and point‑of‑need diagnostics. The effort emphasizes rapid, austere‑environment deployment and seeks innovative host‑targeted and threat‑targeted solutions as well as portable diagnostic platforms to enhance warfighter resilience.